Methenolone Acetate 10 - Livewell Pharmaceuticals

Methenolone acetate, introduced in 1962, marked its U.S. debut under the brand name Nibal® by Squibb. Though briefly available in the American market, it was soon withdrawn due to limited uptake. That same year, the compound was licensed to Schering AG, which rebranded it as Primobolan® in West Germany. There, it gained long-term success, especially in Europe, where it became a staple for treating catabolic states. Its appeal stemmed from its low androgenic index, oral availability, and absence of estrogenic side effects—qualities that made it suitable even for women and pediatric use.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Methenolone Acetate 10 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.